Lantus in Prediabetes

Completed · Phase 1

Conditions studied: Hyperglycemia, Diabetes Mellitus

In brief

To assess the safety, tolerability, and efficacy of Lantus® (insulin glargine) in prediabetes (IFG or IGT).

Key facts

Study ID

NCT00348972

Run by

Sanofi

People needed

20

Starts

2002-02-01

Last updated by the study team

2006-07-06

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Hyperglycemia (either IGT , IFG, or untreated type 2 diabetes)
• HbA1c < 7.0%
• BMI < 40kg/m2
• Able to perform moderate stationary bicycle exercise

You may not qualify if…

• Chronic pharmacologic treatment for hyperglycemia, past or present
• CAD
• serum creatinine > 2.0mg/dL
• BP > 180/105
• History of hypoglycemia unawareness

Where it is running

• Sanofi-Aventis — Bridgewater, New Jersey, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.